Talcum Powder Litigation Report
Hot on the heels of separate $72 million and $55 million verdicts entered against Johnson & Johnson defendants, HarrisMartin has launched this Talcum Powder Litigation Report, an online-only resource dedicated solely to news on talc-based powder ovarian cancer claims.
SEARCH THE ARCHIVES
Issue #35, October 2019
An asbestos cosmetic talcum powder trial against Johnson & Johnson defendants and Imerys Talc America Inc. is scheduled to begin this month in California, according to recent court documents.
HarrisMartin: California Jurors Reach Defense Verdict in Retrial of Cosmetic Talcum Powder Asbestos Case
Jurors in California have reached a defense verdict for Johnson & Johnson at the conclusion of a retrial in a cosmetic talcum powder asbestos case, HarrisMartin Publishing is reporting.
N.J. Federal Court Tosses Shareholder Suit Against J&J, Says Plaintiff Needs to Seek Pre-Suit Demand
A New Jersey federal court has dismissed without prejudice a shareholder suit accusing Johnson & Johnson of withholding information regarding its talcum powder products, concluding that the New Jersey Business Corporation Act does not support a futility exception to pre-suit demand.
Parties awaiting a Daubert ruling from the federal court overseeing the talcum powder national multidistrict litigation docket have filed summation briefs, with the plaintiffs maintaining that their experts have proffered reliable and qualified opinions linking talcum powder usage to ovarian cancer and defendants countering that the plaintiffs’ experts’ opinions lack general acceptance in the scientific community.
Georgia’s first talcum powder ovarian cancer trial has ended in a mistrial, HarrisMartin Publishing is reporting. Jurors informed the court that they was unable to reach a verdict moments ago after a three-week trial and three days of deliberations.
Issue #34, September 2019
Calif. Jury Awards More than $40 Million at Conclusion of Asbestos Talc Trial; No Punitive Damages Awarded
A California jury has awarded plaintiffs asserting asbestos cosmetic talc claims more than $40 million in compensatory damages at the conclusion of a trial against Johnson & Johnson, sources told HarrisMartin Publishing.
Closing arguments in what is Georgia’s first talcum powder ovarian cancer trial are expected to be delivered next week on either Oct. 1 or 2, sources told HarrisMartin Publishing.
N.J. Jury Awards $37.3 Million to 4 Plaintiffs in J&J Asbestos-Talc Trial; Punitive Phase Set for Fall
A New Jersey jury awarded a total of $37.3 million in compensatory damages to four plaintiffs in an asbestos-talc case after determining that their abdominal mesothelioma was caused by their exposure to Johnson & Johnson Baby Powder, sources have confirmed to HarrisMartin Publishing.
Issue #33, August 2019
For the first time, Georgia jurors will have a chance to weigh in on whether talcum powder caused a woman’s ovarian cancer in what is the first case of its kind to proceed to trial in the state.
A Pennsylvania state court has accepted a cosmetic talcum powder mesothelioma case back to its docket, noting that a federal court had rejected Johnson & Johnson’s efforts to remove the case.